The cost of managing a chronic condition has gotten too high

You’ve taken steps to keep your members healthy and to protect them from rising drug costs. Still, the high price tag for life-saving therapies has grown into a serious problem that continues to have a real impact on people’s lives, health and wellbeing.

container
""

Together, we’ve moved a step closer to solving the medication affordability issue

This will help us eliminate the tragic and expensive medical consequences of patient medication rationing.

The cost of rationing

On Jan. 1, 2022, we expanded our market-proven foundation to make more medications accessible in two of the most expensive non-specialty conditions for plan sponsors: diabetes and cardiovascular disease.

54%

increase in RX drug cost from 2006-2016 for total patient out‑of‑pocket spending1

1 in 10

are concerned about the cost of prescription drugs2

~70%

are concerned about the cost of prescription drugs3

A Step Closer.
Express Scripts Patient Assurance® program

A Step Closer. Express Scripts Patient Assurance® program

Lower, predictable costs

We worked to build a program to ensure more value goes toward cost reduction at the point-of-sale, so your members have predictable out-of-pocket costs throughout the year and pay no more than $25 per 34-day Rx on participating products.

Simpler patient experience

When a member fills a prescription for a participating product in the Patient Assurance program, they pay the reduced out-of-pocket amount at the point-of-sale for both the Express Scripts Pharmacy and in-network retail pharmacies.

Higher adherence

By removing cost as an access barrier to medication, members are 30% less likely to abandon their therapy, which can help plans contain the total cost of care for patients living with chronic condition.

Affordable health care

Together, we can change the medication affordability story and make a meaningful difference for your members.

A simple pathway to more affordable, predictable medicine costs

How does this work for my plan?

In order to provide members with immediate access to this predictable $25 out-of-pocket cost per 34-day fill of included prescriptions, even prior to their deductible being satisfied, plans will need to provide first-dollar coverage for participating products. If your current member cost share for participating products is less than $75, there will be no additional cost to your plan or your members. If your current member cost share is more than $75, your plan will need to agree to lower the member’s cost share for participating products to $75 or below to participate in the program.

If you have questions about how this specifically applies to your plan, please contact your account representative.

gentleman

Committed to helping people live healthier lives

The Patient Assurance program was our industry-first approach to delivering a new level of relief and predictability when paying for prescription medications. Now, with a market-proven foundation, we can address additional areas exposed to high out-of-pocket medication costs.

10M lives

offered seamless, affordable access to diabetes medication since the inception of our Patient Assurance program, with more than 240,000 patients benefiting immediately. 

Up to 66%

reduction in out of-of-pocket costs per 34-day fill for many members  via this program. While significant, this is especially critical to those who are experiencing financial difficulty. 

Together, we’re moving a step closer to healthier living with the Patient Assurance program.

While the Patient Assurance program is currently focused on improving affordability and access for your members, we believe that through this program’s continued expansion we can address broader chronic conditions where members may be exposed to higher out-of-pocket medication costs.

couple

Learn how the Patient Assurance program can help manage cost.

Sources

  1. Kaiser Family Foundation, 2006 – 2016
  2. Centers for Disease Control and Prevention
  3. 2020 Medication Access Report https://www.covermymeds.com/main/medication-access-report/